focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

A COVID-19 shot for $150? Online scams surge as slow vaccine rollout frustrates

Tue, 05th Jan 2021 12:00

By Tina Bellon

NEW YORK, Jan 5 (Reuters) - As millions of people await
their turn to get a COVID-19 vaccine that could be months away,
scammers online, in emails and on messaging apps are luring
victims with claims they can deliver shots within days for as
little as $150.

COVID-19 vaccine scams are on the rise, according to
European and U.S. government officials who are warning the
public of fraudsters out for money and personal data.

A Reuters search online, in dark web forums and on messaging
app Telegram found seven different offers for alleged COVID-19
vaccines.

Scams include emails promising entry to supposedly secret
lists for early vaccine access and robocallers impersonating
government agencies. Message boards on the so-called dark web
have added COVID-19 vaccines to more traditional illicit goods
for sale.

The U.S. FBI and Interpol, among others, have warned of
emerging pandemic-related fraud schemes, saying false cures and
vaccines advertised on fake websites could pose cyber threats
and a significant risk to peoples' health, or even lives.

Website domains containing the word vaccine in combination
with COVID-19 or coronavirus more than doubled since October to
roughly 2,500 in November, when the first legitimate vaccines
were nearing regulatory approval, according to cybersecurity
firm Recorded Future, which is tracking COVID-19 fraud online.

"So far a lot of these domains just appear to be
opportunistic registrations, but some are going to be used for
phishing attempts to have people click on (malicious) links,"
said Lindsay Kaye, director of operational outcomes at Recorded
Future.

Kaye said her team, which also scours the dark web, so far
has not come across any legitimate vaccine diverted from
healthcare facilities or national stockpiles.

The scams are preying on concerns about the far
slower-than-promised rollout of vaccines to protect against the
virus that has claimed more than 1.8 million lives worldwide so
far. Most people will likely have to wait well into the spring,
or even summer, to get their shot.

In the United States, only about 4.5 million people had
received their first shot as of Monday, the U.S. Centers for
Disease Control and Prevention reported. That is a fraction of
the 20 million who were supposed to have been vaccinated by the
end of 2020, according to earlier government forecasts.

VACCINES, GUNS AND MONEY

On dark web forum Agartha, fake COVID-19 vaccines were
offered next to cocaine, opioid medication, "super high quality
fake money," hand guns and gift cards. Posts showed stock photos
of vaccines and offered vials for $500 and $1,000, or the
equivalent in Bitcoin.

On another dark web site, a seller claiming to be from the
"Wuhan Institute of Science" offered COVID-19 vaccines in
exchange for a donation, and asked buyers to provide their
medical history.

On Telegram, several channels claimed to offer COVID-19
vaccines, accompanied by stock images. One user offered supposed
Moderna Inc vaccines for $180, and claimed the vaccine
from Pfizer Inc and BioNTech SE could be had
for $150 and AstraZeneca's for $110 per vial.

Asked how the vaccines would be shipped, the account creator
said they were transported in "regulated temperature packs" and
ice packs within a few days, or overnight for an additional
charge.

Actual COVID-19 vaccines, particularly the Pfizer/BioNTech
offering, must be temperature controlled to remain effective,
with drugmakers equipping shipments with temperature trackers to
ensure the cold chain. Vaccine shipments and distribution are
also tightly controlled by officials and will be administered
at no cost.

The United States has so far authorized two COVID-19
vaccines for emergency use - the ones from Pfizer/BioNTech and
Moderna. The European Union to date has authorized the
Pfizer/BioNTech vaccine and is expected to clear the Moderna
vaccine this week.

The UK has already authorized those two and just added the
vaccine developed by Oxford University with AstraZeneca.

Asked about vaccine scams, Pfizer said it had taken
meticulous steps to reduce the risk of counterfeiting and
tracked trends very carefully.

"Patients should never try to secure a vaccine online - no
legitimate vaccine is sold online - and only get vaccinated at
certified vaccination centers or by certified healthcare
providers," a Pfizer spokesman said in a statement.

Moderna referred a request for comment to the U.S.
Department of Health and Human Services (HHS), which did not
respond. AstraZeneca did not respond to a request for comment.

The HHS, FBI and U.S. Department of Justice have urged the
public to report any COVID-19 vaccine scams, including people
asking for out-of-pocket payments for the vaccine and online
vaccine advertisements.

(Reporting by Tina Bellon in New York
Editing by Bill Berkrot)

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.